Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Intravenous Solutions Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Intravenous Solutions Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Crystalloids
1.3.3 Colloids
1.3.4 Others
1.4 Market Segment by Application
1.4.1 Global Intravenous Solutions Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Basic IV Solutions
1.4.3 Nutrient Infusion Solution
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Intravenous Solutions Revenue (2015-2026)
2.1.1 Global Intravenous Solutions Revenue (2015-2026)
2.1.2 Global Intravenous Solutions Sales (2015-2026)
2.2 Intravenous Solutions Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Intravenous Solutions Sales by Regions (2015-2020)
2.2.2 Global Intravenous Solutions Revenue by Regions (2015-2020)
2.3 Global Top Intravenous Solutions Regions (Countries) Ranking by Market Size
2.4 Intravenous Solutions Industry Trends
2.4.1 Intravenous Solutions Market Top Trends
2.4.2 Market Drivers
2.4.3 Intravenous Solutions Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Intravenous Solutions Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Intravenous Solutions Manufacturers by Sales (2015-2020)
3.1.1 Global Intravenous Solutions Sales by Manufacturers (2015-2020)
3.1.2 Global Intravenous Solutions Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Intravenous Solutions Sales in 2019
3.2 Global Top Manufacturers Intravenous Solutions by Revenue
3.2.1 Global Intravenous Solutions Revenue by Manufacturers (2015-2020)
3.2.2 Global Intravenous Solutions Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Intravenous Solutions Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Intravenous Solutions as of 2019)
3.4 Global Intravenous Solutions Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Intravenous Solutions Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Intravenous Solutions Market
3.7 Key Manufacturers Intravenous Solutions Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Intravenous Solutions Historic Market Review by Type (2015-2020)
4.1.2 Global Intravenous Solutions Sales Market Share by Type (2015-2020)
4.1.3 Global Intravenous Solutions Revenue Market Share by Type (2015-2020)
4.1.4 Intravenous Solutions Price by Type (2015-2020)
4.1 Global Intravenous Solutions Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Intravenous Solutions Sales Forecast by Type (2021-2026)
4.2.3 Global Intravenous Solutions Revenue Forecast by Type (2021-2026)
4.2.4 Intravenous Solutions Price Forecast by Type (2021-2026)
5 Global Intravenous Solutions Market Size by Application
5.1 Global Intravenous Solutions Historic Market Review by Application (2015-2020)
5.1.2 Global Intravenous Solutions Sales Market Share by Application (2015-2020)
5.1.3 Global Intravenous Solutions Revenue Market Share by Application (2015-2020)
5.1.4 Intravenous Solutions Price by Application (2015-2020)
5.2 Global Intravenous Solutions Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Intravenous Solutions Sales Forecast by Application (2021-2026)
5.2.3 Global Intravenous Solutions Revenue Forecast by Application (2021-2026)
5.2.4 Intravenous Solutions Price Forecast by Application (2021-2026)
6 North America
6.1 North America Intravenous Solutions Breakdown Data by Company
6.2 North America Intravenous Solutions Breakdown Data by Type
6.3 North America Intravenous Solutions Breakdown Data by Application
6.4 North America Intravenous Solutions Breakdown Data by Countries
6.4.1 North America Intravenous Solutions Sales by Countries
6.4.2 North America Intravenous Solutions Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Intravenous Solutions Breakdown Data by Company
7.2 Europe Intravenous Solutions Breakdown Data by Type
7.3 Europe Intravenous Solutions Breakdown Data by Application
7.4 Europe Intravenous Solutions Breakdown Data by Countries
7.4.1 Europe Intravenous Solutions Sales by Countries
7.4.2 Europe Intravenous Solutions Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Intravenous Solutions Breakdown Data by Company
8.2 Asia Pacific Intravenous Solutions Breakdown Data by Type
8.3 Asia Pacific Intravenous Solutions Breakdown Data by Application
8.4 Asia Pacific Intravenous Solutions Breakdown Data by Regions
8.4.1 Asia Pacific Intravenous Solutions Sales by Regions
8.4.2 Asia Pacific Intravenous Solutions Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Intravenous Solutions Breakdown Data by Company
9.2 Latin America Intravenous Solutions Breakdown Data by Type
9.3 Latin America Intravenous Solutions Breakdown Data by Application
9.4 Latin America Intravenous Solutions Breakdown Data by Countries
9.4.1 Latin America Intravenous Solutions Sales by Countries
9.4.2 Latin America Intravenous Solutions Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Intravenous Solutions Breakdown Data by Type
10.2 Middle East and Africa Intravenous Solutions Breakdown Data by Application
10.3 Middle East and Africa Intravenous Solutions Breakdown Data by Countries
10.3.1 Middle East and Africa Intravenous Solutions Sales by Countries
10.3.2 Middle East and Africa Intravenous Solutions Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Corporation Information
11.1.2 Baxter Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Baxter Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Baxter Intravenous Solutions Products and Services
11.1.5 Baxter SWOT Analysis
11.1.6 Baxter Recent Developments
11.2 Hospira
11.2.1 Hospira Corporation Information
11.2.2 Hospira Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Hospira Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Hospira Intravenous Solutions Products and Services
11.2.5 Hospira SWOT Analysis
11.2.6 Hospira Recent Developments
11.3 B. Braun Melsungen
11.3.1 B. Braun Melsungen Corporation Information
11.3.2 B. Braun Melsungen Business Overview and Total Revenue (2019 VS 2018)
11.3.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 B. Braun Melsungen Intravenous Solutions Products and Services
11.3.5 B. Braun Melsungen SWOT Analysis
11.3.6 B. Braun Melsungen Recent Developments
11.4 Fresenius Kabi
11.4.1 Fresenius Kabi Corporation Information
11.4.2 Fresenius Kabi Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Fresenius Kabi Intravenous Solutions Products and Services
11.4.5 Fresenius Kabi SWOT Analysis
11.4.6 Fresenius Kabi Recent Developments
11.5 Claris Lifesciences
11.5.1 Claris Lifesciences Corporation Information
11.5.2 Claris Lifesciences Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Claris Lifesciences Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Claris Lifesciences Intravenous Solutions Products and Services
11.5.5 Claris Lifesciences SWOT Analysis
11.5.6 Claris Lifesciences Recent Developments
11.6 Grifols
11.6.1 Grifols Corporation Information
11.6.2 Grifols Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Grifols Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Grifols Intravenous Solutions Products and Services
11.6.5 Grifols SWOT Analysis
11.6.6 Grifols Recent Developments
11.7 Vifor Pharma
11.7.1 Vifor Pharma Corporation Information
11.7.2 Vifor Pharma Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Vifor Pharma Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Vifor Pharma Intravenous Solutions Products and Services
11.7.5 Vifor Pharma SWOT Analysis
11.7.6 Vifor Pharma Recent Developments
11.8 JW Life Science
11.8.1 JW Life Science Corporation Information
11.8.2 JW Life Science Business Overview and Total Revenue (2019 VS 2018)
11.8.3 JW Life Science Intravenous Solutions Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 JW Life Science Intravenous Solutions Products and Services
11.8.5 JW Life Science SWOT Analysis
11.8.6 JW Life Science Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Intravenous Solutions Sales Channels
12.2.2 Intravenous Solutions Distributors
12.3 Intravenous Solutions Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Intravenous Solutions Sales Forecast (2021-2026)
13.1.1 Global Intravenous Solutions Sales Forecast by Regions (2021-2026)
13.1.2 Global Intravenous Solutions Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Intravenous Solutions Sales Forecast (2021-2026)
13.2.2 North America Intravenous Solutions Revenue Forecast (2021-2026)
13.2.3 North America Intravenous Solutions Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Intravenous Solutions Sales Forecast (2021-2026)
13.3.2 Europe Intravenous Solutions Revenue Forecast (2021-2026)
13.3.3 Europe Intravenous Solutions Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Intravenous Solutions Sales Forecast (2021-2026)
13.4.2 Asia Pacific Intravenous Solutions Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Intravenous Solutions Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Intravenous Solutions Sales Forecast (2021-2026)
13.5.2 Latin America Intravenous Solutions Revenue Forecast (2021-2026)
13.5.3 Latin America Intravenous Solutions Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Intravenous Solutions Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Intravenous Solutions Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Intravenous Solutions Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
Baxter、Hospira、B. Braun Melsungen、Fresenius Kabi、Claris Lifesciences、Grifols、Vifor Pharma、JW Life Science
【免責事項】
https://www.globalresearch.jp/disclaimer